Detalles de la búsqueda
1.
Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests.
Br J Cancer
; 122(12): 1744-1746, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336753
2.
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Clin Cancer Res
; 20(5): 1298-305, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24520097
Resultados
1 -
2
de 2
1
Próxima >
>>